Nasal fentanyl spray could ease painful eye exams for premature babies

NCT ID NCT07112430

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial tests whether a fentanyl nasal spray can reduce pain during eye exams for retinopathy of prematurity (ROP) in preterm infants. About 58 babies born at or before 31 weeks will receive either fentanyl or a saltwater placebo before their routine exam, along with standard comfort measures like sugar water and swaddling. Researchers will measure pain scores and monitor heart rate, oxygen levels, and side effects to see if the spray is safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
fentanyl citrate (intranasal spray)
What this could lead to
If effective, this could provide a safe, non-invasive way to ease pain during routine eye exams for premature babies.
What could go wrong
This is an early-phase trial with only 58 infants, so results may not apply broadly. Fentanyl carries risks like breathing problems in newborns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANALGESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IWK Health

    Halifax, Nova Scotia, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.